Dogwood Therapeutics (DWTX) Earnings Date, Estimates & Call Transcripts $4.63 +0.11 (+2.43%) Closing price 05/7/2025 04:00 PM EasternExtended Trading$4.69 +0.06 (+1.30%) As of 05/7/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Dogwood Therapeutics Earnings Summary Upcoming Earnings DateMay. 8Before Market OpensEstimatedConsensus EPS (Mar. 31) -$1.49 Actual EPS (Mar. 31) -$6.29 Missed By -$4.80 Dogwood Therapeutics posted Q4 2024 earnings on March 31, 2025, reporting an EPS of -$6.29, which missed analysts' consensus estimates of -$1.49 by $4.80. With a trailing EPS of -$11.34, Dogwood Therapeutics' earnings are expected to grow next year, from ($6.43) to ($4.57) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)DWTX Upcoming EarningsDogwood Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 8, 2025Powered by Get Dogwood Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Dogwood Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataDWTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Dogwood Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.05-$0.48-$0.77Q2 20252-$1.00-$0.51-$0.76Q3 20252-$1.00-$0.54-$0.77Q4 20252-$1.00-$0.57-$0.79 Dogwood Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)--$1.05------3/31/2025Q4 2024-$1.49-$6.29 -$4.80-$6.29--11/7/2024Q3 2024-$1.33-$2.05 -$0.72-$2.05--8/8/2024Q2 2024-$1.75-$1.25+$0.50-$1.25--5/9/2024Q1 2024-$2.00-$1.75+$0.25-$1.75--2/29/2024Q4 2023-$2.25-$1.50+$0.75-$1.50--11/13/2023Q3 2023-$2.50-$1.50+$1.00-$1.50--8/10/2023Q2 2023-$1.75-$2.00 -$0.25-$2.00--5/11/2023Q1 2023--$2.00 -$2.00-$2.00-- Dogwood Therapeutics Earnings - Frequently Asked Questions When is Dogwood Therapeutics's earnings date? Dogwood Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on DWTX's earnings history. Did Dogwood Therapeutics beat their earnings estimates last quarter? In the previous quarter, Dogwood Therapeutics (NASDAQ:DWTX) missed the analysts' consensus estimate of ($1.49) by $4.80 with a reported earnings per share (EPS) of ($6.29). Learn more on analysts' earnings estimate vs. DWTX's actual earnings. How much profit does Dogwood Therapeutics generate each year? Dogwood Therapeutics (NASDAQ:DWTX) has a recorded net income of -$5.30 million. DWTX has generated -$11.34 earnings per share over the last four quarters. What is Dogwood Therapeutics's EPS forecast for next year? Dogwood Therapeutics's earnings are expected to grow from ($6.43) per share to ($4.57) per share in the next year. More Earnings Resources from MarketBeat Related Companies VRCA Earnings Results TNYA Earnings Results CUE Earnings Results BLUE Earnings Results RVPH Earnings Results XLO Earnings Results ATNM Earnings Results SPRO Earnings Results OSTX Earnings Results IRD Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Disney Stock Jumps on Earnings—Is the Magic Sustainable?Archer Stock Eyes Q1 Earnings After UAE UpdatesFord Motor Stock Rises After Earnings, But Momentum May Not Last Broadcom Stock Gets a Lift on Hyperscaler Earnings & CapEx BoostPalantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release? This page (NASDAQ:DWTX) was last updated on 5/8/2025 by MarketBeat.com Staff From Our PartnersTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be la...Porter & Company | Sponsored270x more lucrative than NVIDIA???270x more lucrative than NVIDIA??? If you've missed out on NVIDIA's recent 1,600% run... Don't worry. ...Behind the Markets | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredVanishing BenefitsWhat would you do if your next Social Security check simply never arrived? If you called and the line was d...Investors Alley | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredUrgent News from my Oceanfront Estate Near Mar-a-LagoFor 40 years, I've had a front-row seat to history's greatest wealth creation events. I spotted Microsoft a...InvestorPlace | SponsoredElon’s Been UpgradedThe New Elon Musk is officially stepping back from his day-to-day duties with DOGE. At least, that's the s...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dogwood Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dogwood Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.